Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to

    • Buy Wonderla, Aurobindo Pharma, United Spirits: Rajat Bose

      Rajat Bose of rajatkbose.com suggests buying Wonderla, Aurobindo Pharma and United Spirits.

    • Buy Aurobindo Pharma; sell Thermax: Rajat Bose

      Rajat Bose of rajatkbose.com advises buying Aurobindo Pharma with a target of Rs 909.

    • Bull's Eye: Buy TVS Motor, BEL, Alembic, Auro Pharma

      Krish Subramanyam of Altamount Capital advises buying Alembic with a target of Rs 50.50.

    • Look at Aurobindo Pharma, Dr Reddy's Lab: Dilip Bhat

      According to Dilip Bhat of Prabhudas Lilladher, one may look at Aurobindo Pharma and Dr Reddy's Laboratories.

    • Above Rs 888, Aurobindo Pharma may test Rs 907: Rajat Bose

      Rajat Bose of rajatkbose.com is of the view that above Rs 888, Aurobindo Pharma may test Rs 907.

    • Prefer pharma stocks, says Basant Maheshwari

      Basant Maheshwari, Founder of The Equity Desk And Author of The Thoughtful Investor is of the view that one may prefer pharma stocks.

    • Invest in Aurobindo Pharma, Lupin, Divis Lab: Sukhani

      According to Sudarshan Sukhani of s2analytics.com, Aurobindo Pharma, Lupin and Divis Laboratories are investment ideas.

    • Buy Aurobindo Pharma on every dip: CA Rudramurthy

      CA Rudramurthy BV of Vachana Investments advises buying Aurobindo Pharma on every dip.

    • Buy Aurobindo Pharma, says Chandan Taparia

      Chandan Taparia of Anand Rathi Securities is of the view that one may buy Aurobindo Pharma.

    • Go long in Siemens, says Chandan Taparia

      According to Chandan Taparia of Anand Rathi Securities, one may go long in Siemens.

    • Super Six: Top chart picks for today

      Vishal Malkan of malkansview.com suggests buying Century Textiles with a target of Rs 620.

    • Buy Hindalco, SBI, BEML; like HDFC, DHFL: Prakash Gaba

      Prakash Gaba of prakashgaba.com recommends buying Hindalco Industries on dips and feels that HDFC may test Rs 1290 while DHFL may hit Rs 250.

    • Positive on IT, fin services, logistics cos: Prabhudas L

      R Sreesankar, Head - Institutional Equities, Prabhudas Lilladher, says that while every player having offshore IT centre with higher concentration of its employee base in Chennai will invariably be impacted by the recent floods, he remains positive on the sector.

    • Bull's Eye: Buy PFC, JK Tyre, Aurobindo Pharma, Emami

      Manas Jaiswal of manasjaiswal.com recommends buying Bajaj Hindusthan with a target of Rs 20 and City Union Bank with a target of Rs 97.50.

    • Bull's Eye: Buy Emami, Castrol, Aurobindo Pharma, NOCIL

      Manas Jaiswal of manasjaiswal.com recommends buying Cummins India with a target of Rs 1075 and Mercator with a target of Rs 32.

    • Prefer Aurobindo Pharma, says Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one may prefer Aurobindo Pharma.

    • Like Va Tech Wabag; buy Aurobindo Pharma: R Sreesankar

      R Sreesankar, Head-Institutional Equities at Prabhudas Lilladher likes Va Tech Wabag and feels that one can buy Aurobindo Pharma.

    • Go long in pharma stocks: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can go long in pharma stocks.

    • Hold Aurobindo Pharma, says Ashish Kyal

      Ashish Kyal of wavesstrategy.com is of the view that one may hold Aurobindo Pharma.

    • Super Six stocks that can boost your portfolio on Nov 23

      Ashish Kyal of wavesstrategy.com advises buying Petronet LNG with a target of Rs 243.

    • Bull's Eye: Buy BoI, SAIL, Jet Airways, Kaveri Seed, Gati

      Rakesh Bansal of VP, RK Global advises buying Tata Motors DVR with a target of Rs 311.

    • Buy Aurobindo Pharma, says Daljeet Singh Kohli

      Daljeet Singh Kohli, Head-Research at India Nivesh Securites advises buying Aurobindo Pharma.

    • Buy Aurobindo Pharma, says Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying Aurobindo Pharma.

    • Bull's Eye: Buy Ashok Leyland, UPL, NIIT, SPARC, Aurobindo

      Shahina Mukadam, Independent Market Expert advises buying Ashok Leyland with a target of Rs 94.

    • Short Aurobindo Pharma, says Siddarth Bhamre

      Siddarth Bhamre of Angel Broking advises shorting Aurobindo Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347